Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Citizens JMP has reiterated its Market Perform rating on Piper Sandler (NYSE:PIPR), a $5.3 billion market cap investment bank with a "GREAT" financial health score according to InvestingPro, citing the company’s positive momentum and expanding capabilities.
The firm highlighted Piper Sandler’s recent acquisition of G Squared Capital as an example of how the company continues to add relevant capabilities for clients while expanding its breadth of services.
JMP noted that investor sentiment toward PIPR could continue to improve given its strong positioning with depositories, where there is increasing enthusiasm about potential consolidation in the sector.
The stock has recovered significantly from April’s tariff-driven lows, rising more than 50% and now trading 5% higher year-to-date at approximately 17.1 times JMP’s 2026 estimated earnings per share.
Despite maintaining an upbeat outlook on Piper Sandler’s prospects, JMP believes the current risk/reward balance in the valuation is "relatively fairly balanced," supporting its decision to maintain the Market Perform rating.
In other recent news, Piper Sandler Companies reported strong financial results for the second quarter of 2025, surpassing analysts’ expectations. The company achieved an adjusted earnings per share (EPS) of $2.95, significantly higher than the projected $2.25, representing a 31.11% surprise. Revenue also exceeded forecasts, totaling $396.79 million compared to the anticipated $355.07 million. Additionally, Citizens JMP analyst reiterated a Market Perform rating for Piper Sandler, citing the firm’s competitive positioning and expanding service offerings. These developments reflect the company’s positive momentum as it progresses into the latter half of the year. The reaffirmation from JMP indicates confidence in Piper Sandler’s strategic direction and market standing. Despite the favorable earnings report, the stock experienced a minor decline in pre-market trading. Analysts and investors are closely monitoring these recent developments for future implications.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.